107 related articles for article (PubMed ID: 24636507)
1. Glutamate receptor antibodies directed against AMPA receptors subunit 3 peptide B (GluR3B) can be produced in DBA/2J mice, lower seizure threshold and induce abnormal behavior.
Ganor Y; Goldberg-Stern H; Cohen R; Teichberg V; Levite M
Psychoneuroendocrinology; 2014 Apr; 42():106-17. PubMed ID: 24636507
[TBL] [Abstract][Full Text] [Related]
2. Glutamate receptor antibodies directed against AMPA receptors subunit 3 peptide B (GluR3B) associate with some cognitive/psychiatric/behavioral abnormalities in epilepsy patients.
Goldberg-Stern H; Ganor Y; Cohen R; Pollak L; Teichberg V; Levite M
Psychoneuroendocrinology; 2014 Feb; 40():221-31. PubMed ID: 24485494
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to glutamate receptor subtype 3 (GluR3) are found in some patients suffering from epilepsy as the main disease, but not in patients whose epilepsy accompanies antiphospholipid syndrome or Sneddon's syndrome.
Ganor Y; Goldberg-Stern H; Blank M; Shoenfeld Y; Dobrynina LA; Kalashnikova L; Levite M
Autoimmunity; 2005 Sep; 38(6):417-24. PubMed ID: 16278146
[TBL] [Abstract][Full Text] [Related]
4. Immunization with the glutamate receptor-derived peptide GluR3B induces neuronal death and reactive gliosis, but confers partial protection from pentylenetetrazole-induced seizures.
Ganor Y; Gottlieb M; Eilam R; Otmy H; Teichberg VI; Levite M
Exp Neurol; 2005 Sep; 195(1):92-102. PubMed ID: 15907325
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune epilepsy: some epilepsy patients harbor autoantibodies to glutamate receptors and dsDNA on both sides of the blood-brain barrier, which may kill neurons and decrease in brain fluids after hemispherotomy.
Ganor Y; Goldberg-Stern H; Amrom D; Lerman-Sagie T; Teichberg VI; Pelled D; Futerman AH; Zeev BB; Freilinger M; Verheulpen D; Van Bogaert P; Levite M
Clin Dev Immunol; 2004; 11(3-4):241-52. PubMed ID: 15559370
[TBL] [Abstract][Full Text] [Related]
6. GluR3B Ab's induced oligodendrocyte precursor cells excitotoxicity via mitochondrial dysfunction.
Liu Y; Chen Y; Du WT; Wu XX; Dong FX; Qu XB; Fan HB; Yao RQ
Brain Res Bull; 2017 Apr; 130():60-66. PubMed ID: 28063880
[TBL] [Abstract][Full Text] [Related]
7. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
Levite M
J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
[TBL] [Abstract][Full Text] [Related]
8. Dual-Targeted Autoimmune Sword in Fatal Epilepsy: Patient's glutamate receptor AMPA GluR3B peptide autoimmune antibodies bind, induce Reactive Oxygen Species (ROS) in, and kill both human neural cells and T cells.
Levite M; Zelig D; Friedman A; Ilouz N; Eilam R; Bromberg Z; Ramadhan Lasu AA; Arbel-Alon S; Edvardson S; Tarshish M; Riek LP; Lako RL; Reubinoff B; Lebendiker M; Yaish D; Stavsky A; Galun E
J Autoimmun; 2020 Aug; 112():102462. PubMed ID: 32561150
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to the glutamate receptor kill neurons via activation of the receptor ion channel.
Levite M; Fleidervish IA; Schwarz A; Pelled D; Futerman AH
J Autoimmun; 1999 Aug; 13(1):61-72. PubMed ID: 10441169
[TBL] [Abstract][Full Text] [Related]
10. Autoimmunity to the glutamate receptor in mice--a model for Rasmussen's encephalitis?
Levite M; Hermelin A
J Autoimmun; 1999 Aug; 13(1):73-82. PubMed ID: 10441170
[TBL] [Abstract][Full Text] [Related]
11. Monozygotic twins discordant for epilepsy differ in the levels of potentially pathogenic autoantibodies and cytokines.
Ganor Y; Freilinger M; Dulac O; Levite M
Autoimmunity; 2005 Mar; 38(2):139-50. PubMed ID: 16040334
[TBL] [Abstract][Full Text] [Related]
12. LP-BM5 virus-infected mice produce activating autoantibodies to the AMPA receptor.
Koustova E; Sei Y; Fossom L; Wei ML; Usherwood PN; Keele NB; Rogawski MA; Basile AS
J Clin Invest; 2001 Mar; 107(6):737-44. PubMed ID: 11254673
[TBL] [Abstract][Full Text] [Related]
13. Correlations between the level of antibody against peptide of glutamate receptor NR3B subunit in the CSF and cognitive comorbidities of patients with epilepsy.
Li XY; Hu P; Li QY; Zhang M; Lai QW; Wang X; Fan HB; Yao RQ
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):328-337. PubMed ID: 30657574
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune Epilepsy - Novel Multidisciplinary Analysis, Discoveries and Insights.
Levite M; Goldberg H
Front Immunol; 2021; 12():762743. PubMed ID: 35095841
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune epilepsy: distinct subpopulations of epilepsy patients harbor serum autoantibodies to either glutamate/AMPA receptor GluR3, glutamate/NMDA receptor subunit NR2A or double-stranded DNA.
Ganor Y; Goldberg-Stern H; Lerman-Sagie T; Teichberg VI; Levite M
Epilepsy Res; 2005 Jun; 65(1-2):11-22. PubMed ID: 15978777
[TBL] [Abstract][Full Text] [Related]
16. Removal of anti-Galalpha1,3Gal xenoantibodies with an injectable polymer.
Katopodis AG; Warner RG; Duthaler RO; Streiff MB; Bruelisauer A; Kretz O; Dorobek B; Persohn E; Andres H; Schweitzer A; Thoma G; Kinzy W; Quesniaux VF; Cozzi E; Davies HF; Mañez R; White D
J Clin Invest; 2002 Dec; 110(12):1869-77. PubMed ID: 12488437
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies against an extracellular peptide of the GluR3 subtype of AMPA receptors activate both homomeric and heteromeric AMPA receptor channels.
Cohen-Kashi Malina K; Ganor Y; Levite M; Teichberg VI
Neurochem Res; 2006 Oct; 31(10):1181-90. PubMed ID: 16967334
[TBL] [Abstract][Full Text] [Related]
18. TCR activation eliminates glutamate receptor GluR3 from the cell surface of normal human T cells, via an autocrine/paracrine granzyme B-mediated proteolytic cleavage.
Ganor Y; Teichberg VI; Levite M
J Immunol; 2007 Jan; 178(2):683-92. PubMed ID: 17202328
[TBL] [Abstract][Full Text] [Related]
19. Circulating regulatory anti-T cell receptor antibodies in patients with myasthenia gravis.
Jambou F; Zhang W; Menestrier M; Klingel-Schmitt I; Michel O; Caillat-Zucman S; Aissaoui A; Landemarre L; Berrih-Aknin S; Cohen-Kaminsky S
J Clin Invest; 2003 Jul; 112(2):265-74. PubMed ID: 12865414
[TBL] [Abstract][Full Text] [Related]
20. Identification of amino acids in the glutamate receptor, GluR3, important for antibody-binding and receptor-specific activation.
Carlson NG; Gahring LC; Twyman RE; Rogers SW
J Biol Chem; 1997 Apr; 272(17):11295-301. PubMed ID: 9111034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
